Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women

Atherosclerosis

Volumn 163, Issue 1, 2002, Pages 149-156

  Bloemenkamp, Daisy G M ^a   Mali, Willem P Th M ^a   Tanis, Bea C ^b   Rosendaal, Frits R ^b   Van Den Bosch, Maurice A A J ^a   Kemmeren, Jeanet M ^a   Algra, Ale ^a   Ossewaarde, Jacobus M ^c   Visseren, Frank L J ^a   Van Loon, Anton M ^a   Van Der Graaf, Yolanda ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Atherosclerosis; Infection; Inflammation; Peripheral vascular disease; Risk factors

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ADOLESCENT; AGE DISTRIBUTION; BACTERIAL INFECTION; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CYTOMEGALIC INCLUSION BODY DISEASE; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PERIPHERAL VASCULAR DISEASE; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COHORT STUDIES; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVALS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; INCIDENCE; MIDDLE AGE; NETHERLANDS; PERIPHERAL VASCULAR DISEASES; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0036015996     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00761-4     Document Type: Article

References (42)

1. Chronic infections and coronary heart disease: Is there a link?
2. Atherosclerosis. An inflammatory disease
3. Smoldering arteries? Low-grade inflammation and coronary heart disease
4. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease
5. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
6. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
7. Oral contraceptives and the risk of myocard infarction
8. Random digit dialing in selecting a population-based control group
9. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR)
10. Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis
11. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis
12. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not
13. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile
14. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis
15. Association between chlamydial infection and coronary artery disease
16. Chlamydia pneumoniae infection and atherosclerotic coronary disease
17. Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions
18. Chlamydia pneumoniae in ischemic heart disease
19. Antibody response to the 60-kDa heat-shock protein of Chlamydia pneumoniae in patients with coronary artery disease
20. Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia
21. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly Prospective Heart Disease Study
22. Chlamydia pneumoniae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities Study
23. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women
24. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
25. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: Population based study of coronary heart disease
26. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies
27. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: Large prospective study
28. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis
29. Chlamydia, H. pylori and cytomegalovirus seropositivity and risk of cardiovascular disease: The Framingham Heart Study
30. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: The Cardiovascular Health Study
31. Chlamydia pneumoniae and atherosclerotic risk in populations: The role of seroepidemiology
32. Collaborative multidisciplinary workshop report: The role of epidemiology studies in determining a possible relationship between Chlamydia pneumoniae infection and atherothrombotic diseases
33. Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: Sex-based differences in inflammation and type of immune response
34. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
35. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
36. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease
37. Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study
38. Prospective study of pathogen burden and risk of myocardial infarction or death
39. Infection and atherosclerosis: Potential roles of pathogen burden and molecular mimicry